LONG-TERM RENAL-FUNCTION IN HEART-TRANSPLANT RECIPIENTS RECEIVING CYCLOSPORINE THERAPY

Background: Immunosuppression with cyclosporine has improved alloraft function and reduced both morbidity and mortality in organ transplanta tion. However, cyclosporine-induced nephrotoxicity still is a concern. The purpose of our study was to evaluate the effects of cyclosporine on renal function in orthotopic heart transplant recipients. Methods: Thirty-nine patients who received transplants from 1985 to 1991 and ha d at least three yearly glomerular filtration rate measurements posttr ansplantation by I-125-iothalamate clearance method were included in t he study. In addition, serum creatinine (before and after transplantat ion) and cyclosporine doses were analyzed. Results: Maintenance immuno suppression at 1 year consisted of prednisone (0.1 mg/kg/day), azathio prine (2 mg/kg/day), and cyclosporine (12-hour trough level 100 to 150 ng/ml by fluorescence polarization immunoassay). The mean serum creat inine at 1 year was significantly higher than the mean pretransplantat ion serum creatinine (1.51 +/- 0.32 versus 1.28 +/- 0.38, p < 0.05) an d stabilized after the first year, The mean glomerular filtration rate by I-125-iothalamate clearance method was 70.6 +/- 20.3 ml/min/1.73 m (2) (range 32 to 105) at 1 year and remained relatively stable during the follow-up period of up to 7 years. Creatinine clearance calculated by the Cockcroft and Gault formula overestimated the true glomerular filtration rate after the third year. The mean cyclosporine dosage was significantly lower after the first-year dose of 3.9 +/- 1.8 mglkgi d ay 07 < 0.05), Three patients in 39 started hemodialysis at 5, 7, and 10 years after transplantation. Conclusion: Our data indicate that the adequacy of renal function is preserved with long-term cyclosporine t herapy in heart transplant recipients. J Heart Lung Transplant 1997.